Abstract | INTRODUCTION: MATERIALS AND METHODS: The NRK-52E cells were incubated with LPS with and without the indicated concentrations of emodin for 24 hours. The TLR2 and NF-κB protein level was detected by Western blot method. Tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 protein levels were measured using an enzyme-linked immunosorbent assay. The mRNA expression of TLR2, NF-κB, TNF-α, IL-1β, and IL-6 was detected using a real-time polymersase chain reaction. RESULTS: A concentration of 102 ng/mL of LPS significantly upregulated mRNA and protein levels of TLR2 and NF-κB and increased TNF-α, IL-1β, and IL-6 mRNA and protein levels. At doses of 20 µM and 40 µM, emodin was able to inhibit LPS-induced TLR2, NF-κB, TNF-α, IL-1β and IL-6 mRNA and protein expressions in cultured NRK-52E cells. CONCLUSIONS: These results demonstrate that an elevated expression of inflammatory cytokines and TLR2 in cells stimulated by LPS were simultaneously inhibited by emodin. Therefore, emodin attenuates the inflammation by inhibiting TLR2-mediated NF-κB signal pathway, which may contribute to the immune inflammation regulation of emodin in LPS-induced acute kidney injury.
|
Authors | Ying Li, Weijian Xiong, Jing Yang, Jin Zhong, Ling Zhang, Jing Zheng, Hong Liu, Qi Zhang, Xiaoqin Ouyang, Lei Lei, Xiao Yu |
Journal | Iranian journal of kidney diseases
(Iran J Kidney Dis)
Vol. 9
Issue 3
Pg. 202-8
(May 2015)
ISSN: 1735-8604 [Electronic] Iran |
PMID | 25957424
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Interleukin-1beta
- Interleukin-6
- Lipopolysaccharides
- NF-kappa B
- Protein Kinase Inhibitors
- RNA, Messenger
- Toll-Like Receptor 2
- Tumor Necrosis Factor-alpha
- Emodin
|
Topics |
- Acute Kidney Injury
(chemically induced, drug therapy, immunology)
- Animals
- Cells, Cultured
- Emodin
(pharmacology)
- Enzyme-Linked Immunosorbent Assay
- Epithelial Cells
(drug effects)
- Inflammation
(chemically induced, drug therapy, metabolism)
- Interleukin-1beta
(metabolism)
- Interleukin-6
(metabolism)
- Lipopolysaccharides
(toxicity)
- NF-kappa B
(metabolism)
- Protein Kinase Inhibitors
(pharmacology)
- RNA, Messenger
(drug effects)
- Rats
- Signal Transduction
(drug effects)
- Toll-Like Receptor 2
(metabolism)
- Tumor Necrosis Factor-alpha
(metabolism)
|